Much has changed since certified pharmacists were first able to independently prescribe emergency contraception pills (ECPs) in British Columbia in 2000.
Each year, the UBC Faculty of Pharmaceutical Sciences Alumni Agent of Change Award recognizes one outstanding member of the Pharm Sci alumni family for their remarkable achievements in a clinical, community, education, or research field.
Pharmacy education in British Columbia and Canada continues to advance with the profession. Over the past several decades many pharmacists have earned the Doctor of Pharmacy (PharmD) degree through UBC’s Graduate PharmD Program, or other full-time or part-time programs in the US or other provinces. Learn more about the most recent addition to pharmacy education in BC: UBC’s recently approved Flexible Doctor of Pharmacy (Flex PharmD) degree program
Pharmacy professionals are a humble bunch. All too often those of us who are doing the most innovative things may not have the time, opportunity, or desire to spread the word about what we’re doing and how we’re doing it.
On November 4, the Faculty of Pharmaceutical Sciences at the University of British Columbia (UBC) celebrated its 70th anniversary. As I sit at my desk writing this guest post, I can scarcely begin to imagine what it was like for the 64 students that made up the very first pharmacy class at UBC...
Guest Post: Practice Tools and Resources Developed for Pharmacists, by Pharmacists Now Available On-Line from the UBC Pharmacists Clinic
Read this Guest Post by Barbara Gobis on UBC's Pharmacists Clinic and the practice tools and resources developed for pharmacists, by pharmacists that are now available from the clinic.
Over 213,000 British Columbians age 40 or older took glucose lowering drugs other than insulin during 2015. Of these, 44% took at least two drugs to lower blood sugar.
Read the 100th issue of the UBC Therapeutics Letter on questioning the basis of approval for non-insulin glucose lowering drugs.
Read the Guest Post by Dr. Mary De Vera and Natasha Campbell of the UBC Faculty of Pharmaceutical Sciences.
In six previous Therapeutics Letters, we reported information about the benefits and harms of different proton pump inhibitors (PPIs).These drugs work by irreversibly inhibiting gastric H+K+ ATPase (the proton pump) in the stomach. They inhibit both basal and stimulated acid secretion and are used in a number of clinical settings: gastroesophageal reflux disease (GERD), reflux esophagitis, peptic ulcer disease (PUD), and symptoms associated with stomach acid such as heartburn and acid indigestion.
Read the guest post from UBC Pharmacy Residents Andrea Silver and Andrew Cobleigh.